Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias

Various autoantibodies are associated with clinical outcomes in patients with idiopathic interstitial pneumonias (IIPs). We retrospectively analyzed the association between autoantibodies and malignancies in IIP patients. Comprehensive analyses of autoantibodies were performed using immunoprecipitat...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Takuma Koga, Masaki Okamoto, Minoru Satoh, Kiminori Fujimoto, Yoshiaki Zaizen, Tomonori Chikasue, Akiko Sumi, Shinjiro Kaieda, Norikazu Matsuo, Goushi Matama, Takashi Nouno, Masaki Tominaga, Kazuhiro Yatera, Hiroaki Ida, Tomoaki Hoshino
বিন্যাস: প্রবন্ধ
ভাষা:English
প্রকাশিত: MDPI AG 2022-10-01
মালা:Biomedicines
বিষয়গুলি:
অনলাইন ব্যবহার করুন:https://www.mdpi.com/2227-9059/10/10/2469
_version_ 1827651393930919936
author Takuma Koga
Masaki Okamoto
Minoru Satoh
Kiminori Fujimoto
Yoshiaki Zaizen
Tomonori Chikasue
Akiko Sumi
Shinjiro Kaieda
Norikazu Matsuo
Goushi Matama
Takashi Nouno
Masaki Tominaga
Kazuhiro Yatera
Hiroaki Ida
Tomoaki Hoshino
author_facet Takuma Koga
Masaki Okamoto
Minoru Satoh
Kiminori Fujimoto
Yoshiaki Zaizen
Tomonori Chikasue
Akiko Sumi
Shinjiro Kaieda
Norikazu Matsuo
Goushi Matama
Takashi Nouno
Masaki Tominaga
Kazuhiro Yatera
Hiroaki Ida
Tomoaki Hoshino
author_sort Takuma Koga
collection DOAJ
description Various autoantibodies are associated with clinical outcomes in patients with idiopathic interstitial pneumonias (IIPs). We retrospectively analyzed the association between autoantibodies and malignancies in IIP patients. Comprehensive analyses of autoantibodies were performed using immunoprecipitation and enzyme-linked immunosorbent assays in 193 consecutive IIP patients. Cancer-related factors were analyzed using logistic regression analysis. In total, 22 of 193 patients (11.4%) with IIP had malignant disease. In univariate analysis, positivity for any autoantibody (odds ratio (OR), 3.1; 95% confidence interval (CI), 1.2–7.7; <i>p</i> = 0.017) and antinuclear antibody titer ≥1:320 (OR, 3.4; CI, 1.2–9.8; <i>p</i> = 0.024) were significantly associated with malignancies. Positive anti-aminoacyl tRNA synthetase (ARS) (OR, 3.7; CI, 0.88–15.5; <i>p</i> = 0.074) and anti-Ro52 antibody (OR, 3.2; CI, 0.93–11.2; <i>p</i> = 0.065) tended to be associated with malignancies. In multivariate analysis, independent risk factors were male sex (OR, 3.7; CI, 1.0–13.5; <i>p</i> = 0.029) and positivity for any autoantibody (OR, 3.9; CI, 1.5–10.1; <i>p</i> = 0.004) in model 1, and male sex (OR, 3.9; CI, 1.0–15.3; <i>p</i> = 0.049), antinuclear antibody titer ≥1:320 (OR, 4.2; CI, 1.4–13.3; <i>p</i> = 0.013), and positivity for anti-ARS antibody (OR, 6.5; CI, 1.2–34.1; <i>p</i> = 0.026) in model 2. Positivity for any autoantibody, antinuclear and anti-ARS antibodies, and male sex were independent risk factors for malignancies in IIP patients. Testing autoantibodies in IIP patients might help the early diagnosis of malignancies.
first_indexed 2024-03-09T20:39:06Z
format Article
id doaj.art-906cfb768a5f4414a7399ac800f68052
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T20:39:06Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-906cfb768a5f4414a7399ac800f680522023-11-23T23:03:33ZengMDPI AGBiomedicines2227-90592022-10-011010246910.3390/biomedicines10102469Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial PneumoniasTakuma Koga0Masaki Okamoto1Minoru Satoh2Kiminori Fujimoto3Yoshiaki Zaizen4Tomonori Chikasue5Akiko Sumi6Shinjiro Kaieda7Norikazu Matsuo8Goushi Matama9Takashi Nouno10Masaki Tominaga11Kazuhiro Yatera12Hiroaki Ida13Tomoaki Hoshino14Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, JapanDivision of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, JapanDepartment of Clinical Nursing, School of Health Sciences, University of Occupational and Environmental Health, Fukuoka 807-8555, JapanDepartment of Radiology, Kurume University School of Medicine, Kurume 830-0011, JapanDivision of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, JapanDepartment of Radiology, Kurume University School of Medicine, Kurume 830-0011, JapanDepartment of Radiology, Kurume University School of Medicine, Kurume 830-0011, JapanDivision of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, JapanDivision of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, JapanDivision of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, JapanDivision of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, JapanDivision of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, JapanDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Japan, Fukuoka 807-8555, JapanDivision of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, JapanDivision of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, JapanVarious autoantibodies are associated with clinical outcomes in patients with idiopathic interstitial pneumonias (IIPs). We retrospectively analyzed the association between autoantibodies and malignancies in IIP patients. Comprehensive analyses of autoantibodies were performed using immunoprecipitation and enzyme-linked immunosorbent assays in 193 consecutive IIP patients. Cancer-related factors were analyzed using logistic regression analysis. In total, 22 of 193 patients (11.4%) with IIP had malignant disease. In univariate analysis, positivity for any autoantibody (odds ratio (OR), 3.1; 95% confidence interval (CI), 1.2–7.7; <i>p</i> = 0.017) and antinuclear antibody titer ≥1:320 (OR, 3.4; CI, 1.2–9.8; <i>p</i> = 0.024) were significantly associated with malignancies. Positive anti-aminoacyl tRNA synthetase (ARS) (OR, 3.7; CI, 0.88–15.5; <i>p</i> = 0.074) and anti-Ro52 antibody (OR, 3.2; CI, 0.93–11.2; <i>p</i> = 0.065) tended to be associated with malignancies. In multivariate analysis, independent risk factors were male sex (OR, 3.7; CI, 1.0–13.5; <i>p</i> = 0.029) and positivity for any autoantibody (OR, 3.9; CI, 1.5–10.1; <i>p</i> = 0.004) in model 1, and male sex (OR, 3.9; CI, 1.0–15.3; <i>p</i> = 0.049), antinuclear antibody titer ≥1:320 (OR, 4.2; CI, 1.4–13.3; <i>p</i> = 0.013), and positivity for anti-ARS antibody (OR, 6.5; CI, 1.2–34.1; <i>p</i> = 0.026) in model 2. Positivity for any autoantibody, antinuclear and anti-ARS antibodies, and male sex were independent risk factors for malignancies in IIP patients. Testing autoantibodies in IIP patients might help the early diagnosis of malignancies.https://www.mdpi.com/2227-9059/10/10/2469idiopathic interstitial pneumonialung cancerautoantibodynucleolar antinuclear antibody
spellingShingle Takuma Koga
Masaki Okamoto
Minoru Satoh
Kiminori Fujimoto
Yoshiaki Zaizen
Tomonori Chikasue
Akiko Sumi
Shinjiro Kaieda
Norikazu Matsuo
Goushi Matama
Takashi Nouno
Masaki Tominaga
Kazuhiro Yatera
Hiroaki Ida
Tomoaki Hoshino
Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias
Biomedicines
idiopathic interstitial pneumonia
lung cancer
autoantibody
nucleolar antinuclear antibody
title Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias
title_full Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias
title_fullStr Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias
title_full_unstemmed Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias
title_short Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias
title_sort positive autoantibody is associated with malignancies in patients with idiopathic interstitial pneumonias
topic idiopathic interstitial pneumonia
lung cancer
autoantibody
nucleolar antinuclear antibody
url https://www.mdpi.com/2227-9059/10/10/2469
work_keys_str_mv AT takumakoga positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT masakiokamoto positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT minorusatoh positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT kiminorifujimoto positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT yoshiakizaizen positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT tomonorichikasue positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT akikosumi positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT shinjirokaieda positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT norikazumatsuo positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT goushimatama positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT takashinouno positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT masakitominaga positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT kazuhiroyatera positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT hiroakiida positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias
AT tomoakihoshino positiveautoantibodyisassociatedwithmalignanciesinpatientswithidiopathicinterstitialpneumonias